findmyKOL
Clinical trialNCT01472991CompletedPhase 2Interventional

Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD)

SponsorTargacept Inc.Enrollment250Attention Deficit Hyperactivity Disorder
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Study is to assess if TC-5619 improves symptoms for adults diagnosed with the inattentive-predominant subtype of ADHD over a 4-week treatment period.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Southwestern Research, Inc

    Beverly Hills, California, United States

  • Synergy Clinical Research Center

    National City, California, United States

  • Mcb Clinical Research Centers, Llc

    Colorado Springs, Colorado, United States

  • Florida Clinical Research Center, Llc

    Bradenton, Florida, United States

  • Clinical Neuroscience Solutions, Inc.

    Jacksonville, Florida, United States

  • Florida Clinical Research Center, Llc

    Maitland, Florida, United States

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida, United States

  • Compass Research, Inc.

    Orlando, Florida, United States

  • Compass Research, Llc

    Orlando, Florida, United States

  • Clinical Trials Network & Institute, Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Neuro-Behavioral Clinical Reseach, Inc.

    Canton, Ohio, United States

  • Midwest Clinical Research Center

    Dayton, Ohio, United States

  • Cns Healthcare

    Memphis, Tennessee, United States

  • Futuresearch Clinical Trials, Lp

    Austin, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboTC-5619-238 25mgTC-5619-238 5mg
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2011
Primary completion
31 Jul 2012
Completion
31 Jul 2012
Last update posted
30 Apr 2013
Registered enrollment
250
Registry id
NCT01472991
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.